SCHEMBL6734877

SCHEMBL6734877

CS(=O)(=O)c1c(F)cc(-c2nc(C(F)F)[nH]c2-c2cccc(F)c2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.39
SCD O00767 1/20 0.39
MAPK14 Q16539 4/20 0.38
MAPK13 O15264 3/20 0.38
MAPK12 P53778 3/20 0.38
MAPK11 Q15759 3/20 0.38
RAF1 P04049 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
PLK4 O00444 1/20 0.38
KDM4E B2RXH2 1/20 0.36
PTGS2 P35354 4/20 0.36
PTGS1 P23219 3/20 0.36
TYK2 P29597 2/20 0.35
TNKS2 Q9H2K2 1/20 0.35
SLC9A1 P19634 1/20 0.35
PIN1 Q13526 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6734767 0.90 MAPK14 (0.43) ALOX5MAPK14ALDH1A1HPGDKDM4E
SCHEMBL6740226 0.90 HPGD (0.49) ALOX5MAPK14ALDH1A1HPGDKDM4E
SCHEMBL6735168 0.89 PTGS1 (0.37) ALOX5MAPK14MAPK11ALDH1A1HPGD
SCHEMBL6736661 0.89 MAPK14 (0.39) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL6733875 0.89 IDO1 (0.39) ALOX5SCDMAPK14MAPK13MAPK12
SCHEMBL6729768 0.87 PTGS2 (0.37) ALOX5MAPK14MAPK11ALDH1A1HPGD
SCHEMBL6737269 0.87 PTGS2 (0.49) ALOX5MAPK14MAPK13MAPK12MAPK11
SCHEMBL6731818 0.87 PTGS2 (0.38) ALOX5MAPK14MAPK11ALDH1A1HPGD
SCHEMBL6728169 0.87 MAPK14 (0.44) MAPK14MAPK13MAPK12MAPK11RAF1
SCHEMBL6735176 0.87 PIN1 (0.39) ALOX5MAPK14ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-07-15 US disclosed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed
US-6673818-B2 TREATING CYCLOOXYGENASE-2 MEDIATED DISORDERS, SUCH AS ARTHRITIS, PAIN, FEVER AND CANCER PHARMACIA CORPORATION 2004-01-06 US disclosed
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-08-07 US disclosed
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2003-02-13 US disclosed
EP-1251126-A2 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation Pharmacia Corporation (US) 2002-10-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138261-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 ALOX5 165/4885SCD 1957/4885MAPK14 2311/4885
US-20030149078-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 ALOX5 165/4885SCD 1957/4885MAPK14 2311/4885
US-20030032657-A1 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation FPR1, FPR2, FPR3 ALOX5 165/4885SCD 1957/4885MAPK14 2311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.